BMJ  2008;336:1405 (21 June), doi:10.1136/bmj.39541.731493.59

Head to Head

Should the drug industry work with key opinion leaders? No

Giovanni A Fava, professor of clinical psychology

1 University of Bologna, Italy

giovanniandrea.fava@unibo.it

Feature, doi: 10.1136/bmj.39575.675787.651

Industry commonly works with experts to put across its message. Charlie Buckwell (doi: 10.1136/bmj.39541.702870.59) believes that such interaction is essential for medical advancement, but Giovanni Fava argues that it risks scientific integrity

The first 150 words of the full text of this article appear below.

The proliferating connections between doctors and the drug industry have brought the credibility of clinical medicine to an unprecedented crisis. Corporate actions that have placed profit over public health have become regular news. High profile examples include the misrepresentation of research on rofecoxib and on the use of selective serotonin reuptake inhibitors in children. Recently, two respected scientists who work for a drug company wrote that the problem of conflict of interest "could well erode the credibility of the entire enterprise of academic medicine, if not properly and promptly addressed."1 2

The game is clear: to get as close as possible to universal prescribing of a drug by manipulating evidence and withholding data. A recent paper illustrates how selective publication of trials of antidepressants exaggerated their efficacy.3 Thirty seven of the 38 studies that had positive outcomes were published in peer reviewed journals compared with only three of the 36 studies . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Key opinion leaders, your time is up
Fiona Godlee
BMJ 2008 336: 0. [Extract] [Full Text]

Key opinion leaders: independent experts or drug representatives in disguise?
Ray Moynihan
BMJ 2008 336: 1402-1403. [Extract] [Full Text] [PDF]

Should the drug industry work with key opinion leaders? Yes
Charlie Buckwell
BMJ 2008 336: 1404. [Extract] [Full Text] [PDF]

Paying for the view
Ike Iheanacho
BMJ 2008 336: 160. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Trust me, I'm a doctor.
Michael G Serpell
bmj.com, 30 Jun 2008 [Full text]
Trick or Treat?
Christopher L. Manning
bmj.com, 7 Jul 2008 [Full text]
Key opinion leaders or drug pushers?
Abid Jameel
bmj.com, 3 Sep 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ